Phyllis G. Spivack

Array ( [id] => 8006181 [patent_doc_number] => 08084491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Treatments for wound healing' [patent_app_type] => utility [patent_app_number] => 11/830906 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 27 [patent_no_of_words] => 10279 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084491.pdf [firstpage_image] =>[orig_patent_app_number] => 11830906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029034 [patent_doc_number] => 20070270481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases' [patent_app_type] => utility [patent_app_number] => 11/882109 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2888 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270481.pdf [firstpage_image] =>[orig_patent_app_number] => 11882109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410366 [patent_doc_number] => 08273763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Drugs for the treatment of sarcoglycanopathies' [patent_app_type] => utility [patent_app_number] => 12/374317 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 5392 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490812 [patent_doc_number] => 20090291883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'COMBINATION OF AN IMMUNOSUPPRESSIVE AGENT AND NONSTEROIDAL ANTI -INFLAMMATORY DRUGS TO TREAT DISEASE' [patent_app_type] => utility [patent_app_number] => 12/373841 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24898 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291883.pdf [firstpage_image] =>[orig_patent_app_number] => 12373841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543501 [patent_doc_number] => 08318792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Therapeutic agent for amyotrophic lateral sclerosis' [patent_app_type] => utility [patent_app_number] => 12/374187 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 19641 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496455 [patent_doc_number] => 20090264483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'METHODS OF USING PPAR-gamma AGONISTS AND CASPASE-DEPENDENT CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/373823 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12654 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264483.pdf [firstpage_image] =>[orig_patent_app_number] => 12373823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380325 [patent_doc_number] => 20090192164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Treating agent of inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 12/308750 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9001 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192164.pdf [firstpage_image] =>[orig_patent_app_number] => 12308750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424525 [patent_doc_number] => 20100168078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'S1P RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/303765 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5724 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168078.pdf [firstpage_image] =>[orig_patent_app_number] => 12303765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786208 [patent_doc_number] => 20080139537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'CGRP Antagonists' [patent_app_type] => utility [patent_app_number] => 11/760057 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3065 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139537.pdf [firstpage_image] =>[orig_patent_app_number] => 11760057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126478 [patent_doc_number] => 20070238749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Alpha2delta ligands for the treatment of fibromyalgia and other disorders' [patent_app_type] => utility [patent_app_number] => 11/804789 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8951 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238749.pdf [firstpage_image] =>[orig_patent_app_number] => 11804789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343330 [patent_doc_number] => 20090181980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Synergistic Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 12/299805 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2955 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181980.pdf [firstpage_image] =>[orig_patent_app_number] => 12299805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398351 [patent_doc_number] => 20090318414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Mono and Combination Therapy with M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Prodromal Syndrome' [patent_app_type] => utility [patent_app_number] => 12/226423 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4570 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318414.pdf [firstpage_image] =>[orig_patent_app_number] => 12226423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461031 [patent_doc_number] => 07879870 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists' [patent_app_type] => utility [patent_app_number] => 11/735548 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 9254 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879870.pdf [firstpage_image] =>[orig_patent_app_number] => 11735548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231435 [patent_doc_number] => 20070293543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z' [patent_app_type] => utility [patent_app_number] => 11/734691 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 448 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293543.pdf [firstpage_image] =>[orig_patent_app_number] => 11734691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392252 [patent_doc_number] => 20090209565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 12/296671 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3953 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209565.pdf [firstpage_image] =>[orig_patent_app_number] => 12296671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687424 [patent_doc_number] => 20090176867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'USE OF N-(DIBENZ(B,F)OXEPIN-10-YLMETHYL)-N-METHYL-N-PROP-2-YNYLAMINE OR A PHARMACEUTICALLY ACCEPTABLE ADDITION SALT THEREOF FOR THE PROPHYLAXIS AND/OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY OR MYOPATHY RESULTING FROM COLLAGEN VI DEFICIENCY' [patent_app_type] => utility [patent_app_number] => 12/295801 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3612 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176867.pdf [firstpage_image] =>[orig_patent_app_number] => 12295801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063634 [patent_doc_number] => 20070225274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Methods for modulating bladder function' [patent_app_type] => utility [patent_app_number] => 11/728107 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6796 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225274.pdf [firstpage_image] =>[orig_patent_app_number] => 11728107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374797 [patent_doc_number] => 20090312358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHOD FOR MANAGEMENT OF DIARRHEA' [patent_app_type] => utility [patent_app_number] => 12/294003 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21953 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312358.pdf [firstpage_image] =>[orig_patent_app_number] => 12294003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5447099 [patent_doc_number] => 20090048325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Prophylactic or Therapeutic Agent for Irritable Bowel Syndrome' [patent_app_type] => utility [patent_app_number] => 12/225269 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10831 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048325.pdf [firstpage_image] =>[orig_patent_app_number] => 12225269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 24016 [patent_doc_number] => 07795268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Method of treating hepatic disease using A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/687236 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21866 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795268.pdf [firstpage_image] =>[orig_patent_app_number] => 11687236 [rel_patent_id] =>[rel_patent_doc_number] =>)